Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Stage II Renal Cell Cancer: early-phase trial registry

3 of 5 indexed Stage II Renal Cell Cancer trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Stage II Renal Cell Cancer: 5 US clinical trials tracked, 3 recruiting.

Stage II Renal Cell Cancer is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Jonsson Comprehensive Cancer Center, running 3 of these trials.

Enrollment posture brief

Registry condition stage-ii-renal-cell-cancer

OPEN 3 | RECR 60% | LATE 0 | EARLY 4 | RANK #3391 | SPON 3

Volume-matched condition peers

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Stage II Renal Cell Canc (th…60%
Open-enrollment share among volume-matched conditions near Stage II Renal Cell Cancer

Stage II Renal Cell Cancer lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Stage II Renal Cell Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Stage II Renal Cell Cancer is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Stage II Renal Cell Cancer research.

    Jonsson Comprehensive Cancer Center accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Most Stage II Renal Cell Cancer trials plan to enrol fewer than 100 people.

    Median target enrolment is 37 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.

  4. Stage II Renal Cell Cancer research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 22

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 2

Top Sponsors

Jonsson Comprehensive Cancer Center 3 trials
Children's Oncology Group 1 trials
University of Southern California 1 trials

Named interventions

Most-linked intervention names on Stage II Renal Cell Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Computed Tomography Procedure
3 trials
Magnetic Resonance Imaging Procedure
2 trials
Biospecimen Collection Procedure
2 trials
Interstitial Radiation Therapy Procedure
1 trials
Radioembolization Radiation
1 trials
Angiogram Procedure
1 trials
Conventional Surgery Procedure
1 trials
Irinotecan Hydrochloride Drug
1 trials

US sites by state

Facility locations filed on Stage II Renal Cell Cancer trials. A trial with sites in several states counts in each.

California 5 trials
Connecticut 1 trials
Colorado 1 trials
Arizona 1 trials
Arkansas 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Stage II Renal Cell Cancer page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stage II Renal Cell Cancer condition card totals 5 registered trials; most-linked intervention Computed Tomography; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.